Tanya Dorff, MD

Neeraj Agarwal, MD

GU Oncology Now

In the third part of this peer-to-peer discussion at the 2023 Uromigos Live &amp; Unplugged event, Tanya Dorff, MD, City of Hope, and Neeraj Agarwal, MD, University of Utah, provide an overview of the standard of care for first-line metastatic castration-resistant prostate cancer prior to TALAPRO-2.They then expound on how the standard of care has since changed and what kind of patients were considered for the TALAPRO-2 study.View the other parts of this discussion, including <a href="https://guoncologynow.com/post/talazoparib-plus-enzalutamide-talapro-2-results-and-subset-analyses" target="_blank" rel="noopener">Talazoparib Plus Enzalutamide: TALAPRO-2 Results and Subset Analyses</a>, <a href="https://guoncologynow.com/post/talapro-2-toxicities-and-treatment-duration" target="_blank" rel="noopener">TALAPRO-2: Toxicities and Treatment Duration</a>, and <a href="https://guoncologynow.com/post/importance-of-genomic-testing-for-patients-with-metastatic-prostate-cancer" target="_blank" rel="noopener">Importance of Genomic Testing for Patients With Metastatic Prostate Cancer</a>.

How Has TALAPRO-2 Changed the Standard of Care for First-Line mCRPC With HRR Mutations?

Uromigos Live 2023

Drs. Hope and Agarwal provide an overview of the SOC for 1L mCRPC prior to TALAPRO-2 and how the SOC has since changed.

How Has TALAPRO-2 Changed the SOC for 1L mCRPC With HRR Mutations?

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

The Uromigos

Uromigos Live 2024

AUC3

Localized

mHSPC/mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe